| Name | Title | Contact Details |
|---|
We are an industry leader in the medical device market with a diverse product range including advanced automatic injection devices for drug delivery and innovative blood sampling products including lancets, lancing devices and safety lancets. Established in 1952 by Ivan Owen and John Mumford, we have almost 70 years of experience with offices, manufacturing sites and distributors located around the globe. Our corporate headquarters are located in Woodstock, Oxford UK. We are dedicated to providing innovative healthcare solutions for the management of a variety of medical conditions. With one of the most advanced global research, design and manufacturing capabilities that delivers innovation successfully to improve quality of life, encourage patient compliance, prevent infection and reduce healthcare costs; making a world of difference to a world of people.
NoIR Laser Company is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Intermountain Therapy Animals is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The foundation of the business being laid in 1908 by a profound name Mr. Mohammad Fazal Elahi who started manufacturing instruments with hand and supplied it to the hospitals in the Era of Subcontinent. The company being run under the fourth generation of Mr. Mohammad Fazal Elahi with astounding experiences of more than 30 odd years in the field of surgical innovation and healthcare tools. MEDISYS is committed in providing high quality instruments. Our team is continually working on improving our methods and systems to improve the life and working of our instruments as required by our prestigious customer`s.
Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.